Sign In
Buy CYRX
$16.50
+0.760 (+4.83%)
At Close: Jun 03, 2026
CryoPort, Inc. (CYRX) Expected to Beat Earnings Estimates: Should You Buy?
11:06am, Wednesday, 30'th Apr 2025
CryoPort (CYRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cryoport to Report First Quarter 2025 Financial Results on May 7, 2025
08:30am, Thursday, 24'th Apr 2025
NASHVILLE, Tenn. , April 24, 2025 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global provider of supply chain solutions for the life sciences sector, today announced
Cryoport, Inc. (CYRX) Strategic Agreement and Transaction with DHL Group Call (Transcript)
03:11pm, Monday, 31'st Mar 2025
Cryoport, Inc. (NASDAQ:CYRX ) Strategic Agreement and Transaction with DHL Group Call March 31, 2025 8:30 AM ET Company Participants Todd Fromer - Investor Relations, KCSA Strategic Communications Jer
DHL Group acquires CRYOPDP from Cryoport to strengthen "DHL Health Logistics"
09:06am, Monday, 31'st Mar 2025
DHL to acquire 100% of CRYOPDP, a leading specialty courier providing logistics services for clinical trials, biopharma, and cell & gene therapies. This acquisition enhances DHL's capabilities in spec
NASHVILLE, Tenn. , March 31, 2025 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in supply chain solutions for the life sciences sector, today announced t
NASHVILLE, Tenn. , March 12, 2025 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or "the Company"), a global leader in supply chain solutions for the life sciences, today announced the lau
Cryoport, Inc. (CYRX) Q4 2024 Earnings Call Transcript
08:41pm, Tuesday, 04'th Mar 2025
Start Time: 17:00 January 1, 0000 5:41 PM ET Cryoport, Inc. (NASDAQ:CYRX ) Q4 2024 Earnings Conference Call March 04, 2025, 17:00 PM ET Company Participants Jerrell Shelton - CEO Robert Stefanovich -
CryoPort, Inc. (CYRX) Reports Q4 Loss, Tops Revenue Estimates
06:35pm, Tuesday, 04'th Mar 2025
CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.51 per share a year ago.
Cryoport Reports Fourth Quarter and Full Year 2024 Financial Results
04:10pm, Tuesday, 04'th Mar 2025
FY 2024 revenue of $228.4 million, in-line with company guidance Commercial Cell & Gene Therapy revenue rose to $26 million in FY 2024, up 20% year-over-year Supporting a record total of 701 global cl
Cryoport to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
08:30am, Tuesday, 18'th Feb 2025
NASHVILLE, Tenn. , Feb. 18, 2025 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in supply chain solutions for the life sciences industry, today announced
New Strong Buy Stocks for January 29th
07:16am, Wednesday, 29'th Jan 2025
MC, LFST, EAT, CYRX and HCP have been added to the Zacks Rank #1 (Strong Buy) List on January 29, 2024.
New High-Volume Shipping System, Improving Patient Accessibility, Will Be Showcased by Cryoport Systems at Phacilitate's Advanced Therapies Week in Dallas NASHVILLE, Tenn. , Jan. 21, 2025 /PRNewswire/
Moffitt Cancer Center and Cryoport Announce Strategic Collaboration
08:30am, Tuesday, 14'th Jan 2025
Cryoport's CRYOGENE will provide Moffitt with state-of-the-art biorepository services TAMPA, Fla. and NASHVILLE, Tenn.
Cryoport's MVE Biological Solutions Registers All Manufacturing Facilities with the U.S. Food and Drug Administration ("FDA")
08:30am, Monday, 06'th Jan 2025
All Three MVE Biological Solutions' Manufacturing Facilities Are Registered With the FDA and All Applicable MVE Products Are Now Listed NASHVILLE, Tenn. , Jan. 6, 2025 /PRNewswire/ -- Cryoport, Inc.�
Cryoport Remains A Disappointing Prospect
11:51pm, Sunday, 24'th Nov 2024
Cryoport operates in the promising life sciences sector but continues to suffer from poor fundamentals and significant cash flow challenges. Despite slight revenue growth in Q3 2024, the company remai
